Abu Dhabi launches 3-year fertility fellowship for Emirati doctors

PureHealth and SEHA launched a three-year reproductive medicine and surgery fellowship on 8 October 2026, creating Abu Dhabi's first jointly accredited route for Emirati doctors to qualify as fertility specialists.

The highest-stakes readers are COOs, medical directors and HR heads at fertility clinics. The programme does not change patient eligibility today. It changes the medium-term supply of UAE-trained reproductive medicine specialists, a constraint for clinics competing on IVF access, genetics capability and patient continuity.

What launched, and who regulates it

The SEHA National Fellowship Programme in Reproductive Medicine and Surgery will run at SEHA Corniche Fertility Centre in Abu Dhabi and SEHA Tawam Fertility Centre in Al Ain, according to Gulf News. The programme is open only to Emirati physicians. It combines clinical practice, surgical training, assisted reproductive technology exposure, research and leadership development.

The accreditation comes from the National Institute for Health Specialties and the Department of Health, Abu Dhabi (DOH). Graduates are expected to be licensed as specialists in reproductive medicine and infertility in the UAE. For Dubai operators, fertility centres remain under the Dubai Health Authority (DHA), which issued standards for fertility centres in 2024. In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, facilities are regulated by the Ministry of Health and Prevention (MOHAP).

National healthcare resilience depends on strong clinical capability.
Saeed Jaber Mohd Al Kuwaiti, Group Chief Executive Officer, SEHA

Why clinics and payers should care

For clinic operators, the immediate issue is workforce planning. A three-year fellowship means the first graduates are unlikely to affect specialist availability before 2029, assuming the first cohort starts in the 2026-27 academic cycle. Private IVF providers in Dubai and Abu Dhabi should treat the programme as a signal that government-linked providers are investing in local subspecialty depth, rather than relying only on imported senior consultants.

The commercial angle is narrower but material. IVF is a high-ticket, cash-heavy service line, with coverage often dependent on nationality, plan tier, medical indication and prior authorisation. The UAE Open Healthcare Directory lists typical Dubai fertility consultation prices of AED 800 to AED 2,000 and IVF cycle ranges of AED 15,000 to AED 35,000. For Abu Dhabi, the directory lists IVF treatment at AED 18,000 to AED 45,000, with a typical price of AED 28,000.

• Clinics: review consultant succession plans, embryology capacity and referral protocols before the 2029 specialist pipeline reaches the market.
• Insurers: audit fertility benefit wording for IVF, ICSI, genetic testing, embryo freezing and medication exclusions.
• Patients: request written quotations that separate consultation, stimulation medication, egg retrieval, laboratory procedures, embryo transfer and storage.
• Medical directors: track whether DOH-accredited training becomes a hiring preference for reproductive medicine roles.

Dubai first, then Abu Dhabi and the northern emirates

Dubai remains the most visible private fertility market for many UAE patients, with DHA-regulated providers competing on consultant access, laboratory reputation, package pricing and insurance administration. Abu Dhabi is now adding a workforce and research layer through DOH, SEHA and PureHealth. The northern emirates have a different operating question: whether MOHAP-regulated providers can retain patients who travel to Dubai or Abu Dhabi for IVF, genetics counselling or complex reproductive surgery.

The Abu Dhabi fellowship also fits a wider DOH strategy. In September 2026, DOH announced the Abu Dhabi Reproductive Health Future Programme, with a roadmap to 2030. Gulf News reported that Abu Dhabi had more than 2,000 reproductive health professionals across more than 250 facilities. The fellowship gives that strategy a training mechanism.

For patients, the near-term impact is limited. The fellowship does not create a new reimbursement entitlement, a new cross-emirate licence or a published national IVF price cap. Patients still need to confirm provider licensing with DHA, DOH or MOHAP, then check whether their insurer, including Daman or Thiqa where applicable in Abu Dhabi, covers any part of the treatment pathway.

The practical next step is due diligence. Clinics should monitor DOH licensing outcomes for the first graduating cohort. CFOs should benchmark IVF package pricing against cash-pay competitors each quarter. Patients and referral teams can use the UAE Open Healthcare Directory to compare licensed fertility and IVF providers, regulator status, locations, review volumes and published cost ranges before booking.